The US Food and Drug Administration (FDA) has cleared Medtronic’s Hugo robotic-assisted surgery (RAS) system for use in all upper abdominal general surgical procedures.

The decision broadens the platform’s scope in US healthcare facilities beyond its previous urological indications.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This clearance encompasses all abdominal procedures, such as small bowel resection, cholecystectomy, Roux-en-Y gastric bypass, and ventral hernia repairs. It also authorises lower abdominal operations, specifically appendectomy and inguinal hernia procedures.

Medtronic senior vice-president and surgical business president Matt Anderson said: “For decades, Medtronic has partnered with general surgeons, and we’re bringing that same commitment to robotic surgery for US customers.

“Hugo expands choice with a practical option to help hospitals address capacity and access challenges, while giving surgical teams more flexibility to meet patients’ needs across care settings.”

The platform incorporates modular robotic arms that clinicians can configure according to operative requirements and individual patient anatomy.

It features an open console intended to maintain direct interaction between the operating surgeon, theatre staff, and the patient.

Furthermore, clinicians can deploy Medtronic tools such as the LigaSure RAS Maryland instrument, a vessel-sealing mechanism utilised in over 45 million laparoscopic and open operations.

Hospitals and health networks across the US currently utilise the Hugo RAS system in clinical practice. Outside the US, general surgery accounts for the platform’s fastest procedural growth, outpacing both gynaecology and urology.

Worldwide, procedures using the device are expanding at more than double the pace of the wider robotic surgery sector, with total volume projected to exceed 50,000 cases before the conclusion of the company’s fiscal year.

In September this year, Medtronic received clearance from the FDA clearance for its LigaSure RAS Maryland jaw device for use with the Hugo system.